Edward Neuwelt

1948 -

Edward Neuwelt is an American professor of neurology and neurosurgery at Oregon Health & Science University (OHSU) and the Portland Veterans Affairs Medical Center. He is known for his research on the blood-brain barrier and the development of new treatments for brain tumors. Source: Wikipedia (en)

Series

There is nothing here

Create a new serie

Works

There is nothing here

Create a new work

Articles 252

Date

Title

Authors

2020-02-05

Impact of maintenance rituximab on duration of response in primary central nervous system lymphoma

Edward Neuwelt
2020-01-01

Toll-like Receptor 4 Signaling and Downstream Neutrophilic Inflammation Mediate Endotoxemia-Enhanced Blood-Labyrinth Barrier Trafficking

Edward Neuwelt
2020-06-11

Distinguishing Extravascular from Intravascular Ferumoxytol Pools within the Brain: Proof of Concept in Patients with Treated Glioblastoma

Ramon Barajas Jr, Daniel Schwartz, Heather Mcconnell, Cymon Kersch, Xin Li, Bronwyn Hamilton, Jay Starkey, David Pettersson, Joshua Nickerson, Jeffrey Pollock, R Fu, Andrea Horváth, Laszlo Szidonya, Csanad Varallyay, Jerry Jaboin, Ahmed A Raslan, Aclan Dogan, Justin Cetas, Jeremy Ciporen, Seunggu Jude Han, Prakash Ambady, Leslie Muldoon, Randall Woltjer, William D. Rooney, Edward Neuwelt
2020-12-16

The clinical heterogeneity of entirely nonenhancing CNS lymphoma: a case series

Stephen Bowden, Daniel Munger, S Cody Schoettler Woll, Seunggu Jude Han, Edward Neuwelt, Ramon Barajas Jr, Prakash Ambady
2019-03-01

Combined iron oxide nanoparticle ferumoxytol and gadolinium contrast enhanced MRI define glioblastoma pseudoprogression

Edward Neuwelt
2019-10-22

Multicenter Safety and Practice for Off-Label Diagnostic Use of Ferumoxytol in MRI

Kim-Lien Nguyen, Islam H Zaki, Scott I Semple, Rola Saouaf, David Saloner, Martin R Prince, Mark L Schiebler, Aleksandra Radjenovic, Mustafa R Bashir, Edward Neuwelt
2018-06-01

Sodium Thiosulfate for Protection from Cisplatin-Induced Hearing Loss

Patrizia Dall'Igna, Edward Neuwelt, Piotr Czauderna
2018-07-22

Combination immunotherapy as a non-chemotherapy alternative for refractory or recurrent CNS lymphoma

Edward Neuwelt
2018-09-01

Sodium Thiosulfate and Cisplatin-Induced Hearing Loss

Edward Neuwelt
2018-06-22

MBCL-48. HEARING CHEMOPROTECTION WITH SODIUM THIOSULFATE (STS) IN CHILDREN, ADOLESCENTS AND YOUNG ADULTS WITH STANDARD RISK MEDULLOBLASTOMA

Edward Neuwelt
2018-06-01

Neurovascular Unit: Basic and Clinical Imaging with Emphasis on Advantages of Ferumoxytol

Yueh Lee, Rajan Jain, Edward A. Neuwelt, Heike E Daldrup-Link, Jeffrey J Iliff
2018-01-04

Cerebral blood volume mapping with ferumoxytol in dynamic susceptibility contrast perfusion MRI: Comparison to standard of care

Edward Neuwelt
2017-09-08

Pseudo-extravasation rate constant of dynamic susceptibility contrast-MRI determined from pharmacokinetic first principles

Xin Li, William D. Rooney, Edward Neuwelt
2017-11-06

EXTH-39. EFFICACY OF THE ANTIBODY-DRUG CONJUGATE ABT-414 IN BRAIN TUMOR MODELS

Edward Neuwelt
2017-11-06

HOUT-29. COMORBIDITIES IN SURVIVAL OF ADULTS WITH A GLIOBLASTOMA

Edward Neuwelt
2017-11-06

NTOX-09. RECOMMENDED PHASE II DOSE OF INTRA-ARTERIAL MELPHALAN GIVEN WITH INTRA-ARTERIAL CARBOPLATIN, OSMOTIC BLOOD-BRAIN BARRIER DISRUPTION AND DELAYED OTOPROTECTIVE SODIUM THIOSULFATE FOR PATIENTS WITH RECURRENT OR PROGRESSIVE CNS EMBRYONAL OR GERM CELL TUMORS

Edward Neuwelt
2017-04-20

Current and potential imaging applications of ferumoxytol for magnetic resonance imaging

Gerda B Tóth, Edward Neuwelt, Heike E Daldrup-Link
2017-06-02

Patterns of relapse in primary central nervous system lymphoma: inferences regarding the role of the neuro-vascular unit and monoclonal antibodies in treating occult CNS disease

Edward Neuwelt
2017-03-28

Comprehensive Review of the ThinkFirst Injury Prevention Programs: A 30-Year Success Story for Organized Neurosurgery

Edward Neuwelt
2017-05-11

What Does the Boxed Warning Tell Us? Safe Practice of Using Ferumoxytol as an MRI Contrast Agent

Csanad Varallyay, Gerda B Tóth, R Fu, Joao Prola Netto, Jenny Firkins, Prakash Ambady, Edward Neuwelt
2017-10-03

Dose escalation study of intravenous and intra-arterial N-acetylcysteine for the prevention of oto- and nephrotoxicity of cisplatin with a contrast-induced nephropathy model in patients with renal insufficiency

Gerda B Tóth, Edward Neuwelt
2017-10-27

Abstracts from the 20th International Symposium on Signal Transduction at the Blood-Brain Barriers

Britta Engelhardt, Omolara O Ogunshola, Cherubino Di Lorenzo, Laurence Fenart, Fabien Gosselet, Sabrina Fischer, Lars Winkler, Birger Brodin, Agnes Zvara, László G Puskás, Winfried Neuhaus, Rebecca Johnson, Dan Kho, Catherine Angel, Scott E. Graham, Ismo Virtanen, Ralph M Garruto, Ruth Lyck, Niall P. Pender, Helga E de Vries, Edward A. Neuwelt, Marta Obara-Michlewska, Janina Skipor-Lahuta, Mehmet Kaya, Sheng-Fu Huang, Romain Versele, Mária A. Deli, Peter Vajkoczy, Malgorzata Burek, Kavi Devraj, Jadranka Macas, Holger Gerhardt, Vilmos Tubak, Hans Christian Helms, Helle S. Waagepetersen, Carsten Uhd Nielsen, Nikolett Lénárt, Anna Huber, Hannes Steinkellner, Martin Lauritzen, Simon O'Carroll, Torben Moos, Alwin Kamermans, Lóránd Kiss, Colin P Doherty, Remy Bruggmann, Gijs Kooij, Ignacio A. Romero, David K. Male, Jens Pahnke, Aleksandra Szczepkowska, Marta Kowalewska, Agata Krawczyńska, Andrzej Herman, Magdalena Zielińska, Zygmunt Gizejewski
2017-12-04

Quantitative comparison of delayed ferumoxytol T1 enhancement with immediate gadoteridol enhancement in high grade gliomas

Gerda B Tóth, Edward Neuwelt
2017-08-01

High αv Integrin Level of Cancer Cells Is Associated with Development of Brain Metastasis in Athymic Rats.

Edward Neuwelt
2016-11-30

Effects of sodium thiosulfate versus observation on development of cisplatin-induced hearing loss in children with cancer (ACCL0431): a multicentre, randomised, controlled, open-label, phase 3 trial

Edward Neuwelt
2016-12-20

Misleading early blood volume changes obtained using ferumoxytol-based magnetic resonance imaging perfusion in high grade glial neoplasms treated with bevacizumab

Edward Neuwelt
2016-07-08

Ferumoxytol-enhanced MRI differentiation of meningioma from dural metastases: a pilot study with immunohistochemical observations

Randall L Woltjer, Edward Neuwelt
2016-12-12

Group-Wide, Prospective Study of Ototoxicity Assessment in Children Receiving Cisplatin Chemotherapy (ACCL05C1): A Report From the Children's Oncology Group

Biljana Gillmeister, Edward Neuwelt
2016-12-05

The Translational Significance of the Neurovascular Unit

Randall L Woltjer, Edward Neuwelt
2016-04-09

Ferumoxytol nanoparticle uptake in brain during acute neuroinflammation is cell-specific

Randall L Woltjer, Edward Neuwelt
2016-11-01

Outwitting the Blood-Brain Barrier.

Edward Neuwelt
2015-02-17

Vascular endothelial growth factor blockade alters magnetic resonance imaging biomarkers of vascular function and decreases barrier permeability in a rat model of lung cancer brain metastasis

Edward Neuwelt

Human - wd:Q88044074

Welcome to Inventaire

the library of your friends and communities

learn more